Jacob Gottlieb is the forward-thinking healthcare entrepreneur that is behind Altium Capital. Since its founding, this innovative firm has been making quite a splash in the sector of healthcare investment. The fact is that the healthcare sector is in a state of constant growth and change and Jacob Gottlieb finds himself at the heart of this growth and change. The truth about Altium Capital is that it is one in a long line of innovative healthcare industry investment outfits that Jacob Gottlieb has been involved in during his distinguished entrepreneurial career.
Jacob Gottlieb’s Altium Capital makes its headquarters in the investment hub of New York City, New York and its major focus is squarely on taking advantage of opportunities to invest in healthcare companies that have a great amount of potential. Companies that are innovative in the area of advancements in medical treatments are a major focus that Jacob Gottlieb is concentrating on. Oramed Pharmaceuticals is one of the most promising firms that Altium Capital is making major investments in. Currently, Jacob Gottlieb’s Altium Capital has a stake of 5.6 percent in this exciting company that is working hard to develop innovative treatments in regard to diabetes.
Jacob Gottlieb has also previously founded innovative firms such as Balyasny Asset Management and Visium Asset Management and spent two years working with Sanford C. Bernstein and Co. in the role of analyst. He is also a proud graduate of both Brown University and New York University Medical School.
In an interesting twist, Jacob Gottlieb also now finds himself in the exact same office complex as his former business associate Stuart Weisbrod. Having previously spent a significant amount of time working together with Merlin BioMed, it would now appear that these innovative entrepreneurs are now planning on a new collaboration with one another in the near future.